Barclays maintains Nike at Overweight, lowers price target to $42 from $45

Barclays reaffirmed its Overweight rating on Nike but reduced its price target to $42 from $45, citing a 6.7% decrease. This target suggests a 17.2% upside from Nike's Nov 17 close of $35.85. Recent analyst price targets for Nike range from $29 to $50.

Original reporting
Published Nov 18, 2026, 2:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 2:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Nike at Overweight, lowers price target to $42 from $45 — source image
Decision brief

The 30-second read

$NKEBearishMed
01

Why it matters

The target reduction signals a bearish short‑term outlook, which could trigger sell pressure.

02

Market read

Analyst target cuts are a common catalyst for short‑term price moves; traders may adjust positions accordingly.

03

What to watch

Potential upside from upcoming product launches or international market recovery not reflected in the target.

Relevance 7/10Novelty 7/10Timing: today

Background

Barclays' research note updates its outlook on Nike, a major footwear and apparel company.

Company-level read

Ticker impact

$NKEBearishHigh confidence
Context

Barclays lowered Nike's price target to $42 from $45, indicating a fresh analyst downgrade.

Expected impact

downward pressure as investors price in the lower target

Evidence & confidence

Analyst target cuts are immediate signals that can move the share price, especially when the cut is 6.7%.

Market effects

May weigh on other apparel and consumer discretionary stocks as analysts reassess sector demand.

Limited to U.S. markets where Nike is heavily weighted.

Minor, as Nike is a global brand but the news is a single analyst view.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity.

Key entities

  • Barclays

    Equity research firm providing the price target revision.

  • Nike

    Global athletic apparel and footwear manufacturer.

Related articles

$NKEMedAI 8/10

Why Did Nike Stock Move?

Nike (NKE) shares dropped 6.3% on November 17, 2026, after the company projected revenue declines through fiscal 2028, citing a reset of its sportswear business and challenges in Greater China. The stock's fall was steeper than its peers and the broader market. Nike's outlook extends its previous guidance, with growth expected to return in fiscal 2029. The company's stock has lost 42.3% over the past year.

$NKEMed

JPMorgan raises Nike stock price target on innovation strategy

JPMorgan raised its price target on Nike (NYSE:NKE) to $38.00 from $33.00, maintaining an Underweight rating. The company's 'Accelerate Innovation' strategy was highlighted at its Investor Day, with running cited as a growth area. Nike faces near-term challenges in Nike Sportswear, Jordan, and Greater China, with revenue declining 1.2% over the last twelve months. Several analysts have recently weighed in on Nike's outlook, with mixed ratings and price targets.

$NVDAHighAI 8/10

Nvidia, Salesforce, Nebius Group, Applied Optoelectronics and Nike: Why These 5 Stocks Are on Investors' Radars Today

Nvidia (NVDA) reported Q3 2027 revenue of $115.84B, up 103% YoY, and forecast Q4 revenue of $130B, exceeding estimates. Salesforce (CRM) fell 9.45% due to tech sector selloff. Nebius Group (NBIS) dropped 1.02% amid AI sector concerns. Applied Optoelectronics (AAOI) gained 0.13% but fell 8.67% after-hours due to a $550M stock offering plan. Nike (NKE) declined 6.35% despite new product launches and UEFA deal.

$NKEMed

NIKE Sees Revenue Falling Through 2028, Targets $5 Billion Rebound by 2031

NIKE (NKE) forecasts revenue decline until 2028, targeting a $5B rebound by 2031. Key footwear franchises' revenue expected to drop from $13B to $6B by 2027. China revenue fell 26% in Q1 2027, with stabilization anticipated in 2029. Cost savings of $2.5B by 2031 are planned, with reinvestment under 20%. Growth initiatives include doubling product units and expanding in India.